Abbott Launches Innovative XIENCE Skypoint Stent in India
Abbott has introduced the XIENCE Skypoint, a drug eluting stent designed to treat complex heart blockages in India. The device is noted for its flexibility and precision, aiming to support doctors in managing cardiovascular disease, a leading cause of mortality linked to lifestyle risks in the country.
- Country:
- India
Abbott, a global healthcare leader, announced on Tuesday the release of its innovative drug eluting stent, XIENCE Skypoint, in India. This cutting-edge device is crafted to address complex heart blockages with greater precision and flexibility.
The company highlights the new stent's ability to navigate through the heart's arteries, including larger vessels, providing a significant advancement for cardiovascular treatment. This development is particularly pertinent given the rising incidence of severe blockages attributed to hypertension, diabetes, and other lifestyle factors that are prevalent in India.
Tushar Sharma, general manager of Abbott's vascular division in India and South Asia, emphasized the stent's value in supporting doctors treating cardiovascular disease, asserting the company's commitment to enhancing patient outcomes through advanced medical technologies.
ALSO READ
-
Governor Abbott Secures GOP Primary Win in Texas
-
TRAI Coastal Drive Test in Sundarbans Highlights Strong 5G Performance by Private Operators, Persistent Gaps for BSNL
-
Israeli Prime Minister Benjamin Netanyahu says joint attack with US was to 'remove an existential threat posed' by Iran, reports AP.
-
Congress got 39 pc votes and over 400 seats in 1984, but their votes declined consistently in past four decades: PM Modi.
-
NTPC's Consistent Dividend Delivery: A 33-Year Streak
Google News